ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Guided Spinal Navigation Landmark Surgery Opens the Door to Cost-Effective 3D Augmented Reality

Salt Lake City, May 06, 2025 (GLOBE NEWSWIRE) -- A groundbreaking surgical procedure was successfully performed on a small island in the Mediterranean, marking a significant advancement in spinal surgery. At Hospital Son Llàtzer in Mallorca, Spain, Dr. Juan Toribio, a pioneer in orthopedic surgery, collaborated with Dr. Wendell Gibby, co-inventor of VisAR augmented reality navigation. Together, they performed the first-ever immersive 3D spinal surgery using augmented reality guidance with combined silhouette and X-ray registration. 

What sets this procedure apart is what was not required: there was neither a CT scanner nor a navigation tower in the operating theater. The surgery was carried out in a hospital equipped with standard imaging technology available, including a CT scanner in radiology, and a C-arm in the operating room. 

While spinal navigation has existed for some time, it relies on expensive equipment such as CT scanners and navigation towers, which can cost upwards of $1 million. This financial barrier has limited access to advanced surgical techniques for many healthcare facilities. However, the procedure performed by Dr. Toribio and Dr. Gibby using VisAR demonstrates a disruptive innovation that can be implemented across hospitals of varying socioeconomic levels. 

The VisAR system simply consists of an augmented reality headset worn by the surgeon—no extra computers, towers, monitors, or scanners needed. Prior to the surgery, images were acquired via the CT scanner in radiology, and the patient was then moved to the operating theater. The immersive 3D CT dataset was superimposed onto the patient with a single AP X-ray fluoroscopy shot and patient silhouette registration in immersive 3D augmented reality. This allowed for precise alignment of the patient's real anatomy with the virtual anatomy displayed on the CT scan. With this innovative approach, Dr. Toribio and his associate Dr. Laura Perello were able to navigate four screws into the spine for fusion, as well as a disc insert. 

Following the procedure, Dr. Toribio expressed his enthusiasm for the technology, stating, “After these two days in our hospital, we have been able to confirm that the level of technology you have developed is far superior to what we had imagined. You have to see it to understand it.” He continued, “The moment of greatest satisfaction was when we compared with the X-rays to make sure everything was all right. It was very good.” 

A clinical trial has begun with Dr. Toribio, and additional cases are scheduled this month. These developments highlight the potential for augmented reality to transform surgery across many types of hospitals and surgical centers where legacy navigation is simply not cost-effective. 

About Novarad Corporation:
Novarad Corporation is a leading provider of advanced medical imaging solutions, including cutting-edge augmented reality (AR) technologies. Its innovative products, such as VisAR, are designed to enhance precision and improve outcomes in healthcare. Novarad’s solutions have been widely adopted across various medical disciplines and are paving the way for the future of medical procedures. To learn more, visit https://www.novarad.net/visar.

Attachments


Ashley Wimmer
Novarad Corporation
marketing@novarad.net

Recent Quotes

View More
Symbol Price Change (%)
AMZN  220.69
+3.55 (1.63%)
AAPL  271.49
+5.24 (1.97%)
AMD  203.78
-2.24 (-1.09%)
BAC  51.56
+0.56 (1.10%)
GOOG  299.65
+9.67 (3.33%)
META  594.25
+5.10 (0.87%)
MSFT  472.12
-6.31 (-1.32%)
NVDA  178.88
-1.76 (-0.97%)
ORCL  198.76
-11.93 (-5.66%)
TSLA  391.09
-4.14 (-1.05%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.